Navigation Links
Patient Enrollment Completed in First Randomized Clinical Study of OrbusNeich's Combo™ Bio-engineered Sirolimus Eluting Stent
Date:9/24/2010

sel Revascularization (TVR) and Target Lesion Failure (TLF) rates at the same follow-up times.  The lesions treated are single de novo native coronary lesions ranging in diameter from greater than or equal to 2.5 mm and less than or equal to 3.5 mm and less than or equal to 20 mm in length.

"The concept and design of the Combo Stent can provide a safe alternative for patients with a high risk of restenosis," said Alexandre Abizaid, M.D., Ph.D., director of the catheterization laboratory at the Institute Dante Pazzanese of Cardiology in Sao Paulo, Brazil, and a principal investigator of the study. "We look forward to obtaining data from the REMEDEE study to determine the Combo Stent's potential."

The Combo Stent is designed to combine the pro-healing technology used in OrbusNeich's Genous™ Bio-engineered R stent™ for rapid endothelial coverage with an abluminal sirolimus drug elution for the control of neointimal proliferation.  

About Genous  

Genous is OrbusNeich's patented endothelial progenitor cell (EPC) capture technology that promotes the accelerated natural healing of the vessel wall after the implantation of blood-contact devices such as stents. The technology consists of an antibody surface coating that attracts EPCs circulating in the blood to the device to form an endothelial layer that provides protection against thrombosis and modulates restenosis.

OrbusNeich's Genous Bio-engineered R stent has been commercially available in over 60 countries since 2005. The Genous stent has been proven as a safe, effective alternative to drug-eluting stents and is supported by data from more than 5,000 patients in company-sponsored clinical studies. There is a growing body of evidence from multiple clinical studies that the Genous stent is effective for patients who are non-responsive to or cannot tolerate long-term dual antiplatelet therapy.

About OrbusNeich

OrbusNeich
'/>"/>

SOURCE OrbusNeich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Israele, February 27, 2015 ... suo sviluppo dell,innovativo sistema di monitoraggio dell,infarto congestizio ... trial sull,uomo-     ... sviluppo di nuovo sistema per il monitoraggio cardiaco ... ha annunciato oggi di aver concluso una raccolta ...
(Date:2/27/2015)... and HOUSTON, TX , Feb. 27, ... (TSX-V: EPI) and Bloom Burton & Co. Ltd. ("Bloom ... contractual lock-up (the "Lock-Up") 2,353,130 common shares of the ... originally subject to the Lock-Up. Of the Common Shares ... trading immediately upon release from the Lock-Up while the ...
(Date:2/27/2015)... LONDON , February 27, 2015 ... - new study showing you trends, R&D progress, and ... medicine heading? What are the commercial prospects for ... shows you potential revenues and other trends to 2025, ... ,s report lets you assess regenerative medicine : ...
Breaking Medicine Technology:Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8
... N.J., Oct. 21, 2011 Approximately 100 cherry tree ... today, the newest park in the Morris County Park ... Cherry Lane and celebrate the 100th anniversary ... from Tokyo to Washington D.C. in 1912.  More than ...
... LITTLE FALLS, N.J., Oct. 21, 2011 CANTEL MEDICAL CORP. ... of Directors approved an increase in its semiannual cash dividend to ... is payable on January 31, 2012 to shareholders of record at ... M. Diker, Chairman of the Board, said, "We are pleased to ...
Cached Medicine Technology:Daiichi Sankyo, Inc. Brings the Legacy of Washington, DC Cherry Trees to New Jersey 2Daiichi Sankyo, Inc. Brings the Legacy of Washington, DC Cherry Trees to New Jersey 3Daiichi Sankyo, Inc. Brings the Legacy of Washington, DC Cherry Trees to New Jersey 4Cantel Medical Board of Directors Authorizes Increase in Semiannual Dividend 2
(Date:2/28/2015)... India Network Foundation, a US ... programs for visitors coming to the United States for ... to the United States are suffering from one or ... These diseases are so common among the elderly population ... conditions. There were 66.8 million cases of diabetes in ...
(Date:2/28/2015)... 28, 2015 On Thursday, February 26th, Forbes ... Easy For Scammers To Steal Your Data , which stresses ... hands on a DIY phishing kit, or any kind of ... on another important point about how everyone’s cyber security is ... implemented, “like compromising legitimate content management systems or blogs in ...
(Date:2/28/2015)... 28, 2015 Javon Bea Mercy ... Harvard Hospital as stroke capable by the State of ... ambulance to Mercy Harvard Hospital. , The hospital was ... their ability to treat stroke according to national standards ... transporting stroke patients to bypass hospitals not designated as ...
(Date:2/28/2015)... The World Scout League Commission (WSLC), an organization ... and firefighters, recently announced its decision to host an ... charitable donations for age-related research. The five-kilometer race, which ... on March 29, 2015; registration will start at 2 ... , To participate in the race, runners have ...
(Date:2/27/2015)... 27, 2015 Wireless Analytics, ... and one of the founders of the ... Bell Mobility within their CLEAN Platform™ (Communications Lifecycle ... Wireless Analytics’ newly developed Bell Mobility Data Loader ... Canadian wireless carrier’s business customers. , Wireless Analytics ...
Breaking Medicine News(10 mins):Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4Health News:Mercy Harvard Hospital Recognized as Leader in Stroke Care - Javon Bea 2Health News:Bitcoin Run Is The World Scout League Commission’s Newest Project for Charity 2Health News:Bell Mobility Gains Traction With Enterprises; Is Added to Wireless Analytics’ CLEAN Platform™ 2Health News:Bell Mobility Gains Traction With Enterprises; Is Added to Wireless Analytics’ CLEAN Platform™ 3
... Nurses Launch Online and Telephone Campaign to Flood Blue Cross With ... ... from around the country,have vowed to take up the case of ... to sentence her to a possible lifetime,of disability by denying her ...
... ANN ARBOR. Mich.---Researchers have discovered a way to control ... of new blood vessels, which solves one of ... injuries and trauma in humans. , The procedure could ... or for diabetics or elderly patients who experience wound ...
... The American Association,of Homes and Services for ... work to improve the Medicare SNF payment system, ... patient care., The research presented at today,s ... is adopted, Medicare payments would shift and - ...
... further damage already weakened vessels , , THURSDAY, March 6 (HealthDay ... stroke already faced by people with high blood pressure, researchers ... average age 47, who took part in the Asia Pacific ... participants were smokers at the start of the study. During ...
... 6 Smart Balance Inc. (Nasdaq:,SMBL) will host ... on,March 14, 2008, at 9:30 a.m. EDT to ... issued at approximately 7 a.m. EDT the,same day. ... webcast is also,available through the following link: ...
... Empire Blue Cross Blue Shield has,been fully cooperating with ... to our attention., We were also surprised that ... in our efforts to determine whether the,information provided by ... with the Attorney General,s office in accordance with previously,agreed ...
Cached Medicine News:Health News:Disability by Denial - Blue Cross Rejects Critical Surgery for Orange County ICU Nurse - Woman Possibly Left Disabled by Denial 2Health News:Disability by Denial - Blue Cross Rejects Critical Surgery for Orange County ICU Nurse - Woman Possibly Left Disabled by Denial 3Health News:Researchers control growth rate of replacement blood vessels, tissues 2Health News:Smoking Boosts 'Bleeding' Stroke Risk in Those With High Blood Pressure 2Health News:Smart Balance to Host Webcast/Conference Call on 2007 Fourth-Quarter and Full-Year Results 2
More Info Lacrimal Intubation Set. Size: Probes 23g x 7"....
... Each bath container of the Robot Stainer ... covers that are automatically lifted and transferred ... with the innovative drip preventing system contributes ... and reagent consumption. An acrylic glass cover ...
... field of point of diagnostics pathology, the Leica ... instrument in routine pathology laboratories. With its carrying ... cover, the CM1100 can be transported and operated ... can be run on a car battery simply ...
... OTF5000 represents the new style of ... and reliable OTF/AS cryostat, the new ... in the ever-reliable and powerful 5040 ... plus money-saving package deals makes the ...
Medicine Products: